Profile
Full Name
Moleculin Biotech, Inc.Ticker Symbol
MBRXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 2, 2016Indexes
Not includedWebsite
http://moleculin.comEmployees
17Key Details
Price
$0.80(+9.44%)
Market cap
$10.64M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$6.32(+58.06% YoY)
PE ratio
-
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Moleculin Biotech doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 25, 25 Maxim Group
BuyMar 25, 25 HC Wainwright & Co.
BuyMar 24, 25 HC Wainwright & Co.
BuyMar 3, 25 HC Wainwright & Co.
BuyNov 12, 24 Maxim Group
BuyApr 12, 24 Roth MKM
BuyMar 26, 24 Maxim Group
BuyDec 14, 23 HC Wainwright & Co.
BuyApr 18, 23 Roth MKM
BuyMar 24, 23 Oppenheimer
OutperformInstitutional Ownership
- What is the ticker symbol for Moleculin Biotech?
- Does Moleculin Biotech pay dividends?
- What sector is Moleculin Biotech in?
- What industry is Moleculin Biotech in?
- What country is Moleculin Biotech based in?
- When did Moleculin Biotech go public?
- Is Moleculin Biotech in the S&P 500?
- Is Moleculin Biotech in the NASDAQ 100?
- Is Moleculin Biotech in the Dow Jones?
- When was Moleculin Biotech's last earnings report?
- When does Moleculin Biotech report earnings?
- Should I buy Moleculin Biotech stock now?
What is the ticker symbol for Moleculin Biotech?
The ticker symbol for Moleculin Biotech is NASDAQ:MBRX
Does Moleculin Biotech pay dividends?
No, Moleculin Biotech does not pay dividends
What sector is Moleculin Biotech in?
Moleculin Biotech is in the Healthcare sector
What industry is Moleculin Biotech in?
Moleculin Biotech is in the Biotechnology industry
What country is Moleculin Biotech based in?
Moleculin Biotech is headquartered in United States
When did Moleculin Biotech go public?
Moleculin Biotech's initial public offering (IPO) was on June 2, 2016
Is Moleculin Biotech in the S&P 500?
No, Moleculin Biotech is not included in the S&P 500 index
Is Moleculin Biotech in the NASDAQ 100?
No, Moleculin Biotech is not included in the NASDAQ 100 index
Is Moleculin Biotech in the Dow Jones?
No, Moleculin Biotech is not included in the Dow Jones index
When was Moleculin Biotech's last earnings report?
Moleculin Biotech's most recent earnings report was on Mar 21, 2025
When does Moleculin Biotech report earnings?
The next expected earnings date for Moleculin Biotech is May 13, 2025
Should I buy Moleculin Biotech stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions